Your browser doesn't support javascript.
loading
Bevacizumab as first-line treatment in HER2-negative advanced breast cancer: pros and cons.
Sini, Valentina; Cassano, Alessandra; Corsi, Domenico; De Laurentiis, Michele; Gamucci, Teresa; Mauri, Mariella; Naso, Giuseppe; Roselli, Mario; Ruggeri, Enzo Maria; Tonini, Giuseppe; Vici, Patrizia; Zampa, Germano; Marchetti, Paolo.
Afiliación
  • Sini V; Oncology Unit, Sant'Andrea Hospital, Sapienza University of Rome, and Oncology Unit ASL Roma 1 Santo Spirito Hospital, Rome - Italy.
  • Cassano A; Division of Medical Oncology, Catholic University of Sacred Heart, Rome - Italy.
  • Corsi D; Oncology Unit, San Giovanni Calabita Hospital, Rome - Italy.
  • De Laurentiis M; Department of Breast Oncology, National Cancer Institute "Fondazione Pascale," Naples - Italy.
  • Gamucci T; Medical Oncology Unit ASL Frosinone, Frosinone - Italy.
  • Mauri M; Oncology Unit, San Giovanni Hospital, Rome - Italy.
  • Naso G; Oncology B Unit, Sapienza University of Rome, Rome - Italy.
  • Roselli M; Oncology Unit, Tor Vergata University of Rome, Rome - Italy.
  • Ruggeri EM; Division of Medical Oncology, Belcolle Hospital, ASL Viterbo, Viterbo - Italy.
  • Tonini G; Department of Medical Oncology, University Campus Bio-Medico, Rome - Italy.
  • Vici P; Division of Medical Oncology B, Regina Elena National Cancer Institute, Rome - Italy.
  • Zampa G; Oncology Unit, Nuovo Regina Margherita Hospital, Rome - Italy.
  • Marchetti P; Oncology Unit, Sant'Andrea Hospital, Sapienza University of Rome, and Oncology Unit, IDI-IRCCS, Rome - Italy.
Tumori ; 102(5): 472-480, 2016 Oct 13.
Article en En | MEDLINE | ID: mdl-27647231
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Inhibidores de la Angiogénesis / Bevacizumab / Antineoplásicos Tipo de estudio: Systematic_reviews Límite: Female / Humans Idioma: En Revista: Tumori Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Inhibidores de la Angiogénesis / Bevacizumab / Antineoplásicos Tipo de estudio: Systematic_reviews Límite: Female / Humans Idioma: En Revista: Tumori Año: 2016 Tipo del documento: Article